8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Moderna ($MRNA) announced Q4 2025 financial results on Feb 13, 2026 for the quarter ended Dec 31, 2025 —…
Filed with the SEC on · Summarized by InvestorsBot
Moderna ($MRNA) announced Q4 2025 financial results on Feb 13, 2026 for the quarter ended Dec 31, 2025 — press release furnished as Exhibit 99.1. 📄📈 #earnings #Moderna
The Q4 press release (Exhibit 99.1) is furnished with the Form 8‑K — investors should review it for full revenue, ops and other metrics. $MRNA 🔎 #Q4 #biotech
The filing states the information is “furnished,” not “filed,” so it isn’t subject to Section 18 Exchange Act liabilities and isn’t automatically incorporated by reference into other filings. $MRNA ⚖️ #regulatory #investing